A short story of Klotho and FGF23: A deuce of dark side or the savior?

International Urology and Nephrology

Volumn 46, Issue 3, 2014, Pages 577-581

  Ersoy, F Fevzi ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Cardiovascular disease; Chronic kidney disease; Fibroblast growth factor 23; Klotho; Phosphatonins

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER 2; BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR;

ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; HUMAN; KIDNEY PROXIMAL TUBULE; LIFESPAN; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PHOSPHATE BLOOD LEVEL; PREMATURE AGING; REVIEW; RISK FACTOR; CARDIOVASCULAR DISEASES; COMPLICATION; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

CARDIOVASCULAR DISEASES; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HUMANS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84896943968     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-013-0536-6     Document Type: Review

References (37)

1. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsuki T et al (1997) Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature 390:45-51 (Pubitemid 27494749)
2. Ureña Torres D, Prié V Molina-Blétry, Beck L, Silve C, Friedlander G (2007) An antiaging protein involved in mineral and vitamin D metabolism. Kidney Int 71:730-737
3. Kiela PR, Ghishan FK (2009) Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis. Lab Invest 89:7-14
4. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T et al (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24:3438-3450
5. Urakawa I, Yamazaki Y, Shimada T et al (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF-23. Nature 444:770-774 (Pubitemid 44949607)
6. Nishida Y, Taketani Y, Yamanaka-Okumura H et al (2006) Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70:2141-2147 (Pubitemid 44871378)
7. Berndt TJ, Schiavi S, Kumar R (2005) "Phosphatonins" and the regulation of phosphorus homeostasis. Am J Physiol Renal Physiol. 289:F1170-F1182
8. Shimada T, Kakitani M, Yamazaki Y et al (2004) Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568 (Pubitemid 38542505)
9. Ketteler M, Patrick Biggar H, Liangos O (2013) FGF23 antagonism: the thin line between adaptation and maladaptation in chronic kidney disease. Nephrol Dial Transplant 28:821-825
10. Brownstein CA, Adler F, Nelson-Williams C, Iijima J, Li P, Imura A, Nabeshima Y, Reyes Mugica M, Carpenter TO, Lifton RP (2008) A translocation causing increased alpha-Klotho level results in hypophosphatemic rickets and hyperparathyroidism. PNAS 105(9):3455-3460 (Pubitemid 351723574)
11. Taylor EN, Rimm EB, Stampfer MJ, Curhan GC (2011) Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J 161(5):956-962
12. Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M et al (2010) The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 152(10):640-648
13. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G et al (2009) Fibroblast growth factor-23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119(19):2545-2552
14. Jongbloed F, Galassi A, Cozzolino M, Zietse R, Chiarelli G, Cusi D, Brancaccio D, Gallieni M (2011) Clinical significance of FGF-23 measurement in dialysis patients. Clin Nephrol 76(3):201-209
15. Gutierrez OM, Mannstadt M, Isakova T et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584-592
16. Isakova T, Wahl P, Vargas GS et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370-1378
17. John GB, Cheng CY, Kuro-o M (2011) Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis 58:127-134
18. Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, Jorgetti V, Moysés RM (2011) FGF-23 as a predictor of renal outcome in diabetic nephropathy. CJASN 6(2):241-247
19. Bostrom MA, Hicks PJ, Lu L, Langefeld CD, Freedman BI, Bowden DW (2010) Association of polymorphisms in the Klotho gene with severity of non-diabetic ESRD in African Americans. Nephrol Dial Transplant 25(10):3348-3355
20. Oguro R, Kamide K, Kokubo Y, Shimaoka I, Congrains A, Horio T et al (2010) Association of carotid atherosclerosis with genetic polymorphisms of the Klotho gene in patients with hypertension. Geriatr Gerontol Int. 10(4):311-318
21. Shimoyama Y, Taki K, Mitsuda Y, Tsuruta Y, Hamajima N, Niwa T (2009) Klotho gene polymorphisms G-395A and C1818T are associated with low-density lipoprotein cholesterol and uric acid in Japanese hemodialysis patients. Am J Nephrol 30(4):383-388
22. Jean G, Terrat JC, Vanel T et al (2009) High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long hemodialysis patients. Nephrol Dial Transplant 24:2792-2796
23. Koh N, Fujimori T, Nishiguchi S, Tamori A, Shiomi S, Nakatani T, Sugimura K, Kishimoto T, Kinoshita S, Kuroki T, Nabeshima Y (2001) Severely reduced production of Klotho in human chronic renal failure kidney. Biochem Biophys Res Commun 280:1015-1020 (Pubitemid 32924441)
24. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM (2001) Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938-942 (Pubitemid 34258697)
25. Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA (2012) European uremic toxin (EUTox) Work Group. FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 23(7):2017-2025
26. Schoppet M, Hofbauer LC, Brinskelle-Schmal N, Varennes A, Goudable J, Richard M, Hawa G, Chapurlat R, Szulc P (2012) Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study. J Clin Endocrinol Metab 97(4):E575-E583
27. Hsu HJ, Wu MS (2009) Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 337:116-122
28. Stubbs JR, Liu S, Tang W et al (2007) Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 18:2116-2124 (Pubitemid 47041077)
29. Ashikaga E, Honda H, Suzuki H et al (2010) Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients. Ther Apher Dial 14(3):315-322
30. Inaba M, Okuno S, Imanishi Y et al (2006) Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients. Osteoporosis Int 17(10):1506-1513 (Pubitemid 44387485)
31. Tamei N, Ogawa T, Ishida H et al (2011) Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis. J Atheroscler Thromb 18:217-223
32. Roos M, Lutz J, Salmhofer H et al (2008) Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol 68(4):660-665 (Pubitemid 351388700)
33. Kojima F, Uchida K, Ogawa T et al (2008) Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Int Urol Nephrol 40:1067-1074
34. Moldovan D, Moldovan I, Rusu C, Kacso I, Patiu IM, Gherman-Caprioara M (2013) FGF-23, vascular calcification and cardiovascular diseases in chronic hemodialysis patients. Int Urol Nephrol. doi:10.1007/s11255-013-0422-2
35. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 1(1):31-38 (Pubitemid 44967731)
36. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C (2009) Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75:88-95
37. Prié D, Friedlander G (2010) Reciprocal Control of 1,25-Dihydroxyvitamin D and FGF23 Formation Involving the FGF23/Klotho System. Clin J Am Soc Nephrol 5:1717-1722